HEM Pharma Inc. (KOSDAQ:376270)

Market Cap	141.37B
Revenue	n/a
Net Income	n/a
Shares Out	7.07M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,169
Average Volume	13,115
Open	18,600
Previous Close	18,600
Day's Range	18,420 - 19,500
52-Week Range	11,520 - 26,000
Beta	n/a
RSI	48.03
Earnings Date	Aug 20, 2025

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang-si, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 376270